Method, Nephelometric, Immunoglobulins (g, A, M)
Immunology · 21 CFR 866.5510
Recent MDR events
24 adverse event reports on file
- VITROS CHEMISTRY PRODUCTS IGA REAGENTJan 30, 2024MalfunctionOrtho-clinical Diagnostics, Inc.1319808-2024-00001
- IGM IMMUNOGLOBULIN MFeb 28, 2022MalfunctionRoche Diagnostics1823260-2022-00530
- VITROS CHEMISTRY PRODUCTS IGA REAGENTAug 5, 2019MalfunctionOrtho-clinical Diagnostics1319808-2019-00024
- VITROS CHEMISTRY PRODUCTS IGA REAGENTAug 5, 2019MalfunctionOrtho-clinical Diagnostics1319808-2019-00023
- VITROS CHEMISTRY PRODUCTS IGA REAGENTAug 5, 2019MalfunctionOrtho-clinical Diagnostics1319808-2019-00021
- VITROS CHEMISTRY PRODUCTS IGA REAGENTAug 5, 2019MalfunctionOrtho-clinical Diagnostics1319808-2019-00022
- VITROS CHEMISTRY PRODUCTS IGA REAGENTAug 5, 2019MalfunctionOrtho-clinical Diagnostics1319808-2019-00028
- VITROS CHEMISTRY PRODUCTS IGA REAGENTAug 5, 2019MalfunctionOrtho-clinical Diagnostics1319808-2019-00025
- VITROS CHEMISTRY PRODUCTS IGA REAGENTAug 5, 2019MalfunctionOrtho-clinical Diagnostics1319808-2019-00026
- VITROS CHEMISTRY PRODUCTS IGA REAGENTAug 5, 2019MalfunctionOrtho-clinical Diagnostics1319808-2019-00027
Event type breakdown
Recalls
20 recall events for this product code
- Beckman Coulter Inc.Open, ClassifiedJul 24, 2024
Beckman Coulter, REF: OSR61173, IGM 4x14 mL R1, 4x11 mL R2
LIH Influence check settings for Lipemia are incorrect which may result patient samples being reported as false low results or cause a high result to report as normal
Z-2428-2024 · View FDA record ↗ - Siemens Healthcare Diagnostics, Inc.Open, ClassifiedFeb 7, 2024
Total immunoglobulin M (IgM total) IVD, kit, nephelometry/turbidimetry
Potential for a negative bias with quality control (QC) and patient sample results when using the Atellica CH Immunoglobulin M_2 (IgM_2) reagent.
Z-1003-2024 · View FDA record ↗ - Beckman Coulter Inc.Open, ClassifiedAug 31, 2023
Beckman Coulter, IVD, REF: OSR61171, IgA, 4 x 14 mL R1, 4 x 11 mL R2
Lipemic interference failed to meet the performance specification listed within the IFU.
Z-2488-2023 · View FDA record ↗ - SIEMENS HEALTHCARE DIAGNOSTICS INCOpen, ClassifiedOct 14, 2022
N Antiserum to Human IgG, 2mL Variant for BN II System and BN ProSpec System-IVD
N Antiserum to Human IgG are not meeting the current High-Dose Hook Effect expectation of up to 648 mg/L for IgGU (urine) and up to 2290 mg/L for IgGC (CSF).
Z-0093-2023 · View FDA record ↗ - SIEMENS HEALTHCARE DIAGNOSTICS INCOpen, ClassifiedOct 14, 2022
N Antiserum to Human IgG, 5mL Variant for BN II System and BN ProSpec System- IVD
N Antiserum to Human IgG are not meeting the current High-Dose Hook Effect expectation of up to 648 mg/L for IgGU (urine) and up to 2290 mg/L for IgGC (CSF).
Z-0094-2023 · View FDA record ↗ - The Binding Site Group, Ltd.TerminatedDec 13, 2018
Binding Site Human IgM Kit (for SPAPLUS), REF: NK012.S
Firm is offering advice to customers experiencing challenges when validating the calibration curve of the IgM kits. This is indicated by kit control values reporting outside the specified ranges.
Z-0604-2019 · View FDA record ↗ - The Binding Site Group, Ltd.TerminatedNov 17, 2018
Binding Site Human IgM Kit (for SPAPLUS), REF: NK012.S
After running the calibration curve, the recovery of the IgM kit control results decrease demonstrating a reduction in accuracy within the same day; control results may be out of range one day after running the assay calibration curve. Samples have been shown to be similarly affected.
Z-0477-2019 · View FDA record ↗ - The Binding Site Group, Ltd.TerminatedJan 23, 2017
Human Subclass Kit for use on the Beckman IMMAGE"/IMMAGE"800 Analyser
Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.
Z-1067-2017 · View FDA record ↗ - The Binding Site Group, Ltd.TerminatedJan 23, 2017
Human lgG4 Subclass kit for use on the Beckman Coulter AU"
Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.
Z-1068-2017 · View FDA record ↗ - The Binding Site Group, Ltd.TerminatedJan 23, 2017
Human lgG4 Subclass Liquid Reagent Kits For use on the
Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.
Z-1069-2017 · View FDA record ↗
Registered firms
67 firms currently registered for this product code
The Binding Site Group Ltd.
BIRMINGHAM, GB
The Binding Site
Kings Norton Birmingham, GB
Roche Diagnostics Gmbh
MANNHEIM Baden-Wurttemberg, DE
Siemens Healthcare Diagnostics Products Gmbh
MARBURG Hesse, DE
Ortho-clinical Diagnostics, Inc.
Rochester, NY, US
Beckman Coulter, Inc.
BREA, CA, US
Diafarma Ecza Deposu Ve Medikal Dis Ticaret Dis Tic Ltd Sti
Istanbul, TR
Diamond Diagnostics Inc.
Budapest, HU
Siemens Healthcare Diagnostics Inc.
Tarrytown, NY, US
Roche Diagnostics Gmbh
PENZBERG Bavaria, DE
Beckman Coulter, Inc.
CARLSBAD, CA, US
Ortho-clinical Diagnostics European Support Center
Illkirch, CEDEX Bas-Rhin, FR
510(k) clearances
61 clearances for this product code
- Siemens Healthcare Diagnostics Products GmbHDec 13, 2023
K233663 · N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)
- Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd.Aug 2, 2023
K221114 · Immunoglobulin G (IgG)
- The Binding Site Group , Ltd.Sep 4, 2019
K192116 · Human IgA liquid reagent kit for Use on SPAPlus
- The Binding Site Group , Ltd.Aug 19, 2019
K191985 · Optilite IgA Kit
- The Binding Site Group , Ltd.Jul 15, 2019
K191635 · Optilite IgM Kit
- The Binding Site Group , Ltd.Jun 27, 2019
K191465 · Human IgM Kit for use on SPAPlus
- The Binding Site Group , Ltd.May 28, 2019
K190686 · Optilite IgM CSF Kit
- The Binding Site Group , Ltd.Jan 23, 2019
K183151 · Optilite IgA CSF Kit